Everolimus-eluting vs. paclitaxel-eluting coronary stents in the treatment of small vessels: pooled results of the SPIRIT III and SPIRIT IV randomized clinical trials through 2 years
Background Higher rates of adverse cardiac events have been observed in patients with small vessel disease. In a pooled analysis of the SPIRIT III and IV trials, we compared an…